The Debrief  ·  No. 13

Week of September 23 – September 30, 2026

Week of September 23 – September 30, 2026: no new recruiting · no new Field Notes.

0 new recruiting0 new Field Notes

New here? The Debrief is the weekly research read from Psychedelic Vets — the same veteran research we’ve been sharing at Microdosing Vets, now in one place.

Featured study

Microdosing Vets

A veteran-led study documenting how veterans actually use microdosing — a qualitative look at real experience, not a clinical trial. If you’re a U.S. veteran, a short screening will tell you whether you’re a fit.

Take the 5-minute screening →

1Newly recruiting this week

No new studies opened to veterans this week.

2Still recruiting

Open now, from the directory — not new this week.

Psilocybin as a Treatment for Chronic Pain in Smokers
Veterans 21–65 who smoke daily, with chronic pain · Connecticut · Yale University
View study →
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Adults 18+ with PTSD diagnosed 6+ months ago · Florida · COMPASS Pathways
View study →
Ketamine for Veterans With Parkinson's Disease
Veterans 40–80 with Parkinson's · California · VA Office of Research and Development
View study →

3Field Notes — from the archive

No new Field Notes this week — ones worth revisiting.

In a controlled trial in veterans, smoked cannabis did not reduce PTSD symptoms more than a placebo.
Randomized double-blind cross-over · n = 80
Read the field note →
In a retrospective case series at a VA clinic, veterans with both depression and PTSD had lower PTSD and depression scores over their first weeks of nasal-spray ketamine.
Retrospective case series · n = 35
Read the field note →
After a combined ibogaine and 5-MeO-DMT treatment, Special Operations veterans reported improvements in PTSD, depression, and anxiety at one month, with signs of lasting benefit to six months.
Observational program eval · n = 86
Read the field note →

4One thing worth knowing

A veteran org we point to
Healing Breakthrough

Veteran-led funding and advocacy to open MDMA-assisted therapy access through the VA.

Learn about their work →
The Debrief
Weekly Research Dispatch

The week in veteran psychedelic research — what's newly recruiting, what the latest studies found, and one thing worth knowing. A two-minute read, every Wednesday.